Insider · CIK 0001366074

Lappe Mark

Reports to the SEC for 4 companies · LA JOLLA, CA

sec.gov

Transactions

Companies

Filings

CIK

0001366074

Forms 4 and 5

Insider transactions

50 trades

Date	Company	Role	Code	Shares	Price	Value	Shares after
2026-10-14	INBXInhibrx Biosciences, Inc.P Purchase	Director, Chief Executive Officer	PPurchase	+2,470 sh	$84.07	+$208K	743,018
2026-10-14	INBXInhibrx Biosciences, Inc.P Purchase	Director, Chief Executive Officer	PPurchase	+2,470 sh	$85.00	+$210K	745,488
2026-10-14	INBXInhibrx Biosciences, Inc.P Purchase	Director, Chief Executive Officer	PPurchase	+100 sh	$85.76	+$8,576	745,588
2026-10-14	INBXInhibrx Biosciences, Inc.P Purchase	Director, Chief Executive Officer	PPurchase	+2,449 sh	$84.07	+$206K	167,449
2026-10-14	INBXInhibrx Biosciences, Inc.P Purchase	Director, Chief Executive Officer	PPurchase	+2,451 sh	$85.00	+$208K	169,900
2026-10-14	INBXInhibrx Biosciences, Inc.P Purchase	Director, Chief Executive Officer	PPurchase	+100 sh	$85.76	+$8,576	170,000
2026-09-28	INBXInhibrx Biosciences, Inc.P Purchase	Director, Chief Executive Officer	PPurchase	+1,500 sh	$98.88	+$148K	737,548
2026-09-28	INBXInhibrx Biosciences, Inc.P Purchase	Director, Chief Executive Officer	PPurchase	+3,000 sh	$101.70	+$305K	740,548
2026-09-25	INBXInhibrx Biosciences, Inc.P Purchase	Director, Chief Executive Officer	PPurchase	+3,324 sh	$98.87	+$329K	733,872
2026-09-25	INBXInhibrx Biosciences, Inc.P Purchase	Director, Chief Executive Officer	PPurchase	+2,176 sh	$99.60	+$217K	736,048
2026-09-08	INBXInhibrx Biosciences, Inc.P Purchase	Director, Chief Executive Officer	PPurchase	+5,895 sh	$99.29	+$585K	711,443
2026-09-08	INBXInhibrx Biosciences, Inc.P Purchase	Director, Chief Executive Officer	PPurchase	+6,605 sh	$100.64	+$665K	718,048
2026-09-08	INBXInhibrx Biosciences, Inc.P Purchase	Director, Chief Executive Officer	PPurchase	+1,100 sh	$107.12	+$118K	719,148
2026-09-08	INBXInhibrx Biosciences, Inc.P Purchase	Director, Chief Executive Officer	PPurchase	+500 sh	$108.23	+$54.1K	719,648
2026-09-08	INBXInhibrx Biosciences, Inc.P Purchase	Director, Chief Executive Officer	PPurchase	+1,219 sh	$111.88	+$136K	720,867
2026-09-08	INBXInhibrx Biosciences, Inc.P Purchase	Director, Chief Executive Officer	PPurchase	+9,681 sh	$112.28	+$1.09M	730,548
2024-09-16	INBXInhibrx Biosciences, Inc.P Purchase	Director, Chief Executive Officer	PPurchase	+13K sh	$17.13	+$223K	705,548
2024-09-12	INBXInhibrx Biosciences, Inc.P Purchase	Director, Chief Executive Officer	PPurchase	+27K sh	$15.05	+$406K	692,511
2024-09-10	INBXInhibrx Biosciences, Inc.P Purchase	Director, Chief Executive Officer	PPurchase	+8,500 sh	$15.19	+$129K	665,548
2024-09-09	INBXInhibrx Biosciences, Inc.P Purchase	Director, Chief Executive Officer	PPurchase	+9,500 sh	$15.21	+$144K	657,048
2024-09-06	INBXInhibrx Biosciences, Inc.P Purchase	Director, Chief Executive Officer	PPurchase	+26K sh	$15.29	+$398K	647,548
2024-09-03	INBXInhibrx Biosciences, Inc.P Purchase	Director, Chief Executive Officer	PPurchase	+15.3K sh	$15.66	+$239K	160,288
2024-09-03	INBXInhibrx Biosciences, Inc.P Purchase	Director, Chief Executive Officer	PPurchase	+4,712 sh	$16.31	+$76.9K	165,000
2024-08-30	INBXInhibrx Biosciences, Inc.P Purchase	Director, Chief Executive Officer	PPurchase	+10K sh	$14.02	+$140K	145,000
2024-08-29	INBXInhibrx Biosciences, Inc.P Purchase	Director, Chief Executive Officer	PPurchase	+10K sh	$14.03	+$140K	135,000
2024-08-21	INBXInhibrx Biosciences, Inc.P Purchase	Director, Chief Executive Officer	PPurchase	+12.9K sh	$12.93	+$167K	54,865
2024-08-20	INBXInhibrx Biosciences, Inc.P Purchase	Director, Chief Executive Officer	PPurchase	+27.1K sh	$12.97	+$351K	41,920
2024-05-30	INBXInhibrx Biosciences, Inc. · Stock Option (right to buy)A Award	Director, Chief Executive Officer	AAward	+300K sh	—	—	300,000
2024-05-30	Inhibrx, Inc.D Disposition to Issuer	Director, Chief Executive Officer	DDisposition to Issuer	−2.49M sh	$30.00	−$74.6M	0
2024-05-30	Inhibrx, Inc.D Disposition to Issuer	Director, Chief Executive Officer	DDisposition to Issuer	−500K sh	$30.00	−$15M	0
2024-05-30	Inhibrx, Inc.D Disposition to Issuer	Director, Chief Executive Officer	DDisposition to Issuer	−59.5K sh	$30.00	−$1.78M	0
2024-05-30	Inhibrx, Inc.Stock Option (right to buy)D Disposition to Issuer	Director, Chief Executive Officer	DDisposition to Issuer	−100K sh	—	—	0
2024-05-30	Inhibrx, Inc.Stock Option (right to buy)D Disposition to Issuer	Director, Chief Executive Officer	DDisposition to Issuer	−145K sh	—	—	0
2024-05-29	INBXInhibrx Biosciences, Inc.A Award	Director, Chief Executive Officer	AAward	+622K sh	—	—	621,548
2024-05-29	INBXInhibrx Biosciences, Inc.A Award	Director, Chief Executive Officer	AAward	+125K sh	—	—	125,000
2024-05-29	INBXInhibrx Biosciences, Inc.A Award	Director, Chief Executive Officer	AAward	+14.9K sh	—	—	14,865
2023-02-28	Inhibrx, Inc.S Sale	Director, Chief Executive Officer	SSale	−60 sh	$25.02	−$1,501.248	2,486,192
2023-01-24	Inhibrx, Inc.S Sale	Director, Chief Executive Officer	SSale	−4,272 sh	$25.71	−$110K	2,486,315
2023-01-24	Inhibrx, Inc.S Sale	Director, Chief Executive Officer	SSale	−63 sh	$26.11	−$1,645.1	2,486,252
2023-01-23	Inhibrx, Inc.S Sale	Director, Chief Executive Officer	SSale	−21.7K sh	$25.36	−$549K	2,490,587
2023-01-03	Inhibrx, Inc.Stock Option (right to buy)A Award	Director, Chief Executive Officer	AAward	+100K sh	—	—	100,000
2022-12-19	Inhibrx, Inc.S Sale	Director, Chief Executive Officer	SSale	−25.2K sh	$25.53	−$645K	2,513,006
2022-12-19	Inhibrx, Inc.S Sale	Director, Chief Executive Officer	SSale	−754 sh	$26.29	−$19.8K	2,512,252
2022-11-17	Inhibrx, Inc.S Sale	Director, Chief Executive Officer	SSale	−6,959 sh	$25.36	−$176K	2,557,293
2022-11-17	Inhibrx, Inc.S Sale	Director, Chief Executive Officer	SSale	−4,106 sh	$26.57	−$109K	2,553,187
2022-11-17	Inhibrx, Inc.S Sale	Director, Chief Executive Officer	SSale	−4,333 sh	$27.45	−$119K	2,548,854
2022-11-17	Inhibrx, Inc.S Sale	Director, Chief Executive Officer	SSale	−1,767 sh	$28.86	−$51K	2,547,087
2022-11-17	Inhibrx, Inc.S Sale	Director, Chief Executive Officer	SSale	−6,773 sh	$30.15	−$204K	2,540,314
2022-11-17	Inhibrx, Inc.S Sale	Director, Chief Executive Officer	SSale	−912 sh	$30.67	−$28K	2,539,402
2022-11-17	Inhibrx, Inc.S Sale	Director, Chief Executive Officer	SSale	−1,150 sh	$32.38	−$37.2K	2,538,252

Recent filings

Accepted (ET)
Oct 144
Lappe Mark0001366074-26-000006
SEC(opens sec.gov)
Sep 284
Lappe Mark0001366074-26-000004
SEC(opens sec.gov)
Sep 84
Lappe Mark0001366074-26-000002
SEC(opens sec.gov)
Sep 164
Lappe Mark0002007919-24-000049
SEC(opens sec.gov)
Sep 104
Lappe Mark0002007919-24-000045
SEC(opens sec.gov)

Companies

Address

C/O INHIBRX BIOSCIENCES, INC. 11025 NORTH TORREY PINES ROAD, SUITE 140

LA JOLLA, CA, 92037